U.S. President Donald Trump meets with pharmaceutical industry representatives at the White House in Washington, U.S. on January 31, 2017. U.S. President Donald Trump meets with pharmaceutical industry representatives at the White House in Washington, U.S. on January 31, 2017.
Category: Pharmaceuticals
Drug company fined $150 million for not reporting suspicious orders
A prescription drug wholesale company was handed a record fine Tuesday on allegations from U.S. regulators for not reporting suspicious orders of painkillers. McKesson Corporation will pay a $150 million fine and stop selling certain drugs in Colorado, Ohio, Florida and Michigan after it avoided its own internal systems to avoid inconsistent or outsize orders of drugs such as oxycodone and hydrocodone that are linked to the national opioid epidemic, the Department of Justice announced on Tuesday.
Bragar Eagel & Squire, P.C. Reminds Investors of a Class Action…
Bragar Eagel & Squire, P.C. Reminds Investors of a Class Action Lawsuit Against Impax Laboratories, Inc. and the Lead Plaintiff Deadline of January 9, 2017 Bragar Eagel & Squire, P.C. Reminds Investors of a Class Action Lawsuit Against Impax Laboratories, Inc. and the Lead Plaintiff Deadline of January 9, 2017 Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of all persons or entities who purchased or otherwise acquired Impax Laboratories, Inc. securities between February 20, 2014 and November 3, 2016 .